The search for a reliable and accurate respiratory rate monitor for use in non-intubated patients has proved to be a long and fruitless one. A new device fulfilling the criteria for such a monitor has ...

The addition of oscillations to PEP therapy has been proposed to enhance ... 19] ATS/ERS: Joint American Thoracic Society/European Respiratory Society COPD management guidelines; COPDX: Australian ...

It also holds your airways open, keeping them from closing. Although your respiratory therapist may suggest a different way to use PEP based on your unique circumstances, typically, people perform 10 ...

The global oscillating positive expiratory pressure device market is set to witness remarkable expansion, with recent market analyses estimating its valuation at USD 151.30 million by the end of 2024.

PEP-010 is under clinical development by PEP-Therapy and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase I drugs for Pancreatic Ductal Adenocarcinoma does not ...

PEP-010 is under clinical development by PEP-Therapy and currently in Phase I for Metastatic Ovarian Cancer. According to GlobalData, Phase I drugs for Metastatic Ovarian Cancer have a 77% phase ...